BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25961037)

  • 1. The R21C Mutation in Cardiac Troponin I Imposes Differences in Contractile Force Generation between the Left and Right Ventricles of Knock-In Mice.
    Liang J; Kazmierczak K; Rojas AI; Wang Y; Szczesna-Cordary D
    Biomed Res Int; 2015; 2015():742536. PubMed ID: 25961037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
    Wang Y; Pinto JR; Solis RS; Dweck D; Liang J; Diaz-Perez Z; Ge Y; Walker JW; Potter JD
    J Biol Chem; 2012 Jan; 287(3):2156-67. PubMed ID: 22086914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation.
    Cheng Y; Rao V; Tu AY; Lindert S; Wang D; Oxenford L; McCulloch AD; McCammon JA; Regnier M
    J Biol Chem; 2015 Nov; 290(46):27749-66. PubMed ID: 26391394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
    Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
    J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.
    McKee LA; Chen H; Regan JA; Behunin SM; Walker JW; Walker JS; Konhilas JP
    Arch Biochem Biophys; 2013 Jul; 535(1):39-48. PubMed ID: 23352598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.
    Cheng Y; Lindert S; Oxenford L; Tu AY; McCulloch AD; Regnier M
    J Phys Chem B; 2016 Aug; 120(33):8238-53. PubMed ID: 27150586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mavacamten decreases maximal force and Ca
    Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
    J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventricular differences in myofilament function in experimental congestive heart failure.
    Belin RJ; Sumandea MP; Sievert GA; Harvey LA; Geenen DL; Solaro RJ; de Tombe PP
    Pflugers Arch; 2011 Dec; 462(6):795-809. PubMed ID: 21927813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
    Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
    FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
    Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.
    Chandra V; Gollapudi SK; Chandra M
    Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1260-70. PubMed ID: 26342069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
    Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
    FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
    Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
    Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and Molecular Characterisation of Heart Failure Progression in Mice and the Role of Myosin Regulatory Light Chains in the Recovery of Cardiac Muscle Function.
    Markandran K; Yu H; Song W; Lam DTUH; Madathummal MC; Ferenczi MA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
    Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myosin Rod Hypophosphorylation and CB Kinetics in Papillary Muscles from a TnC-A8V KI Mouse Model.
    Kawai M; Johnston JR; Karam T; Wang L; Singh RK; Pinto JR
    Biophys J; 2017 Apr; 112(8):1726-1736. PubMed ID: 28445763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers.
    Mickelson AV; Chandra M
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1180-H1189. PubMed ID: 28842439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.